High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era
Author:
Funder
(Hospital Clínic, Barcelona)
“Becas de Investigación de la FEHH”
(Instituto de Salud Carlos III)
“Fellowship Programme”
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference40 articles.
1. Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study;Bachy;J. Clin. Oncol.,2019
2. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study;Casulo;J. Clin. Oncol.,2015
3. Transformation of indolent B-cell lymphomas;Montoto;J. Clin. Oncol.,2011
4. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group;Alonso-Álvarez;Br. J. Haematol.,2017
5. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis;Federico;Lancet Haematol.,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F;Cancers;2023-02-04
2. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis;Annals of Hematology;2022-08-27
3. Overcoming tumor resistance mechanisms in CAR-NK cell therapy;Frontiers in Immunology;2022-08-03
4. Identification of Hub Genes and Key Pathways Associated with Follicular Lymphoma;Contrast Media & Molecular Imaging;2022-07-31
5. Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma;Internal Medicine;2022-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3